I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Propper, David J.
115
results:
Search for persons
X
Format
Online (115)
Mediatypes
Articles (Online) (61)
Bookchapter (Online) (5)
OpenAccess-fulltext (49)
Sorted by: Relevance
Sorted by: Year
?
1
Targeting super-enhancers in refractory pancreatic cancer:
Propper, David
;
Borazanci, Erkut
;
Han, Haiyong
...
Pancreatology. 23 (2023) 4 - p. e5 , 2023
Link:
https://doi.org/10.1016/..
?
2
Clinical trials for pancreatic cancer:
Propper, David
;
Basu, Bristi
Pancreatology. 23 (2023) 4 - p. e3 , 2023
Link:
https://doi.org/10.1016/..
?
3
A super-enhancer-regulated RNA-binding protein cascade driv..:
Antal, Corina E.
;
Oh, Tae Gyu
;
Aigner, Stefan
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
4
The impact of chemotherapy on cognitive performance post‐su..:
Dwek, Marie‐Rose
;
Newman, Stanton P.
;
Brini, Stefano
...
Psycho-Oncology. 32 (2023) 7 - p. 1057-1066 , 2023
Link:
https://doi.org/10.1002/..
?
5
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signal..:
Propper, David J.
;
Gao, Fangfei
;
Saunders, Mark P.
...
British Journal of Cancer. 128 (2022) 2 - p. 245-254 , 2022
Link:
https://doi.org/10.1038/..
?
6
Author Correction: The VAR2CSA malaria protein efficiently ..:
Agerbæk, Mette Ø.
;
Bang-Christensen, Sara R.
;
Yang, Ming-Hsin
...
Nature Communications. 13 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
7
Harnessing cytokines and chemokines for cancer therapy:
Propper, David J.
;
Balkwill, Frances R.
Nature Reviews Clinical Oncology. 19 (2022) 4 - p. 237-253 , 2022
Link:
https://doi.org/10.1038/..
?
8
STARPAC clinical trial:
Kocher, Hemant M.
;
Basu, Bristi
;
Froeling, Fieke EM.
...
Pancreatology. 20 (2020) 8 - p. e17 , 2020
Link:
https://doi.org/10.1016/..
?
9
Phase I clinical trial repurposing all-trans retinoic acid ..:
Kocher, Hemant M.
;
Basu, Bristi
;
Froeling, Fieke E. M.
...
Nature Communications. 11 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1038/..
?
10
The VAR2CSA malaria protein efficiently retrieves circulati..:
Agerbæk, Mette Ø.
;
Bang-Christensen, Sara R.
;
Yang, Ming-Hsin
...
Nature Communications. 9 (2018) 1 - p. , 2018
Link:
https://doi.org/10.1038/..
?
11
A phase I trial of the γ-secretase inhibitor MK-0752 in com..:
Cook, Natalie
;
Basu, Bristi
;
Smith, Donna-Michelle
...
British Journal of Cancer. 118 (2018) 6 - p. 793-801 , 2018
Link:
https://doi.org/10.1038/..
?
12
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine ..:
Iveson, Timothy J
;
Kerr, Rachel S
;
Saunders, Mark P
...
The Lancet Oncology. 19 (2018) 4 - p. 562-578 , 2018
Link:
https://doi.org/10.1016/..
?
13
SCOT: a comparison of cost-effectiveness from a large rando..:
Robles-Zurita, José
;
Boyd, Kathleen A.
;
Briggs, Andrew H.
...
British Journal of Cancer. 119 (2018) 11 - p. 1332-1338 , 2018
Link:
https://doi.org/10.1038/..
?
14
Remodelling of microRNAs in colorectal cancer by hypoxia al..:
Nijhuis, Anke
;
Thompson, Hannah
;
Adam, Julie
...
Human Molecular Genetics. 26 (2017) 8 - p. 1552-1564 , 2017
Link:
https://doi.org/10.1093/..
?
15
Vandetanib plus gemcitabine versus placebo plus gemcitabine..:
Middleton, Gary
;
Palmer, Daniel H
;
Greenhalf, William
...
The Lancet Oncology. 18 (2017) 4 - p. 486-499 , 2017
Link:
https://doi.org/10.1016/..
1-15